| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 12/02/2004 | US20040241671 Sequences involved in phenomena of tumour suppression, tumour reversion, apoptosis and/or virus resistance and their us as medicines |
| 12/02/2004 | US20040241657 Nucleotide sequences which hybridizes to variant/allelic sequence in haplotype block for use in diagnosis and prognosis of hepatic and inflammatory disorders |
| 12/02/2004 | US20040241642 Polynucleotide fragments of an infections human endogenous retrovirus |
| 12/02/2004 | US20040241640 Internalisation of virus into cells |
| 12/02/2004 | US20040241639 Human tachykinin-related splice variants and compositions thereof |
| 12/02/2004 | US20040241249 Prepared by ketone extraction of krill; evaporating ketone in liquid product; 2nd extraction of the solids in the product with an alcohol or acetate solvent to form a soluble lipid fraction; separating liquids and solids in 2nd product and evaporating solvent from liquid fraction; recovering solids |
| 12/02/2004 | US20040241248 Crosslinking the carboxylic acid groups in a glycosaiminoglycan with a primary amine in a lipid to form particles that can be used to encapsulate various drugs, especially chemotherapeutic agents |
| 12/02/2004 | US20040241230 Modulated release from biocompatible polymers |
| 12/02/2004 | US20040241229 Sustained-release composition and process for producing the same |
| 12/02/2004 | US20040241217 Method for administration of immune modulators in systemic and localized immune disorders |
| 12/02/2004 | US20040241204 Sustained release pharmaceutical composition |
| 12/02/2004 | US20040241192 Administering a tryptanthrin compound, e.g., 8-nitroindolo[2,1-b]quinazoline-6,12-dione, to potentiate the immune response to an antigen; immunostimulants; small molecule immune potentiators; immunotherapy for infectious diseases; anticarcinogenic agents; vaccine adjuvant compositions and kits |
| 12/02/2004 | US20040241182 lymphocytes; immunogens; fusion proteins; for treatment/prevention of infection |
| 12/02/2004 | US20040241180 Notch |
| 12/02/2004 | US20040241179 Compositions and methods using lactadherin or variants thereof |
| 12/02/2004 | US20040241171 Leukocyte inactivation module |
| 12/02/2004 | US20040241168 Compositions and methods for the treatment and clinical remission of psoriasis |
| 12/02/2004 | US20040241167 CD4/CD25 antigen containing cell, interleukin, CD8/CD28 antigen containing cell, and vitamin D3; for generating tolerogenic antigen-presenting cell; kits; for treatment of autoimmune diseases such as AIDS, cancer, and Hepatitis C-related disorders |
| 12/02/2004 | US20040241166 Use of inhibitors of ikk-beta and method for discovery of said inhibitors |
| 12/02/2004 | US20040241165 RFamide-Related Peptide-3 (RFRP-3); orphan g protein coupled receptors; for promoting prolactin secretion; treating hypoovarianism, seminal vesicle hypoplasia, menopausal syndrome and hypothyroidism |
| 12/02/2004 | US20040241163 Secreted human cytomegalovirus protein or fragment thereof binds rantes chemokine; for treating chemokine-associated inflammatory or immune pathological conditions such as transplant rejection, arteriosclerosis, rheumatoid arthritis, asthma, endometriosis, and cancer |
| 12/02/2004 | US20040241161 Methods and means for use of hla-dq restricted t-cell receptors and hla-dq-binding prolamine-derived peptides |
| 12/02/2004 | US20040241157 Collagenolytic activity; glycosaminoglycans; drug screening; kits; for treatment of osteoporosis, skin aging, Paget's disease, and rheumatoid arthritis |
| 12/02/2004 | US20040241156 Gene expression inhibition; solid phase synthesis; drug screening; for treating cancer, central nervous system disorders, and chronic obstructive pulmonary disorder |
| 12/02/2004 | US20040241154 Secretin for the treatment of asthma |
| 12/02/2004 | US20040241152 Methods for inducing an immune response with an elevated th1/th2 ratio, by intracellular induction of nfkappab |
| 12/02/2004 | US20040241149 prevention or prophylaxis of inflammatory condition comprising administering lactic acid bacteria containing unmethylated cytosine-guanine (cpg) dinucleotide to modulate the cytokine response of human or animal immune system; antiinflammatory agents |
| 12/02/2004 | US20040241147 antigen presenting cells which express major histocomatibility complexes, used as vaccines |
| 12/02/2004 | US20040241140 Expression vectors able to elicit improved immune response and methods of using same |
| 12/02/2004 | US20040241138 Methods of treating liver fibrosis |
| 12/02/2004 | US20040241137 vaccines comprising antigen bearing targets and fusion polypeptide having amino acid sequences which can bind to a carbohydrate and serve as and ligands for cell surface polypeptide of leukocytes |
| 12/02/2004 | US20040241129 Amphiphilic complexes, method for their preparation and compositions containing them |
| 12/02/2004 | US20040241116 Using zinc glycoprotein |
| 12/02/2004 | US20040238597 Isolated human secreted proteins, nucleic acid molecules encoding human secreted proteins, and uses thereof |
| 12/02/2004 | DE10321725A1 Enzymhaltige Zusammensetzungen, daraus hergestellte diätetische Lebensmittel und Arzneimittel und ihre Verwendung für medizinische Zwecke Enzyme-containing compositions, dietetic foods and medicines prepared therefrom and their use for medical purposes |
| 12/02/2004 | CA2557625A1 Method of treatment of systemic injury secondary to burns |
| 12/02/2004 | CA2528521A1 Disease prevention and vaccination prior to thymic reactivations |
| 12/02/2004 | CA2526651A1 Immunosuppressive effects of pteridine derivatives |
| 12/02/2004 | CA2526493A1 Means for preventing and treating cellular death and their biological applications |
| 12/02/2004 | CA2526393A1 Antisense oligonucleotides directed to ribonucleotide reductase r1 and uses thereof in the treatment of cancer |
| 12/02/2004 | CA2526069A1 Modified antiviral peptides with increased activity and cell membrane affinity |
| 12/02/2004 | CA2525831A1 Process for manufacture of nematode-extracted anticoagulant protein (nap) |
| 12/02/2004 | CA2525804A1 Use of chondroitinase abc enzyme for the treatment of cns injuries |
| 12/02/2004 | CA2525771A1 Combination therapy with glatiramer acetate and mitoxantrone for the treatment of multiple sclerosis |
| 12/02/2004 | CA2525696A1 Control of function of intracellular ca ion |
| 12/02/2004 | CA2525574A1 Stable analogs of peptide and polypeptide therapeutics |
| 12/02/2004 | CA2525304A1 Recombinant gene medicine of adenovirus vector and gene p53 for treating proliferative diseases |
| 12/02/2004 | CA2525224A1 Protein stabilization in solution |
| 12/02/2004 | CA2525181A1 Tnf-like secreted protein |
| 12/02/2004 | CA2525168A1 Compositions for delivering peptide yy and pyy agonists |
| 12/02/2004 | CA2525012A1 Protein kinase c zeta as a drug target for arthritis and other inflammatory diseases |
| 12/02/2004 | CA2524950A1 Methods for facilitating recovery of functions of endogenous or implanted or transplanted stem cells using high molecular weight hyaluronic acid |
| 12/02/2004 | CA2524936A1 Compositions and methods for the preparation of human growth hormone glycosylation mutants |
| 12/02/2004 | CA2524818A1 Protein kinase c peptides for use in withdrawal |
| 12/02/2004 | CA2524707A1 Repeat sequence protein polymer active agent conjugates, methods and uses |
| 12/02/2004 | CA2524538A1 Solid particles comprising an anticonvulsant or an immunosuppressive coated with one or more surface modifiers |
| 12/02/2004 | CA2523467A1 Treatment of t-cell mediated diseases |
| 12/02/2004 | CA2469528A1 Peptide and peptide mimetic derivatives having integrin inhibitor properties iii |
| 12/02/2004 | CA2466430A1 Process for the preparation of cyclic peptides |
| 12/01/2004 | EP1482052A1 Modified polypeptides for targeting cell-entry of the adenoviruses of subtype B |
| 12/01/2004 | EP1482046A2 G-CSF analog compositions and methods |
| 12/01/2004 | EP1482045A2 G-CSF analog compositions and methods |
| 12/01/2004 | EP1482044A2 Multivariant IL-3 hematopoiesis fusion protein |
| 12/01/2004 | EP1482042A1 Active and inactive CC-chemokine receptors and nucleic acid molecules encoding said receptor |
| 12/01/2004 | EP1482041A1 Nnl6 tie receptor tyrosine kinase ligand homologues |
| 12/01/2004 | EP1482040A2 NL3 TIE receptor tyrosine kinase ligand homologues |
| 12/01/2004 | EP1482038A1 Novel protein and dna thereof |
| 12/01/2004 | EP1482037A1 Inhibition of gene expression by delivery of specially selected double stranded or other forms of small interfering RNA precursors enabling the formation of small interfering RNA in vivo and in vitro |
| 12/01/2004 | EP1482034A1 Novel oxidase |
| 12/01/2004 | EP1481991A1 Allergenic protein of natural rubber |
| 12/01/2004 | EP1481989A1 A-33 related antigens and their pharmacological uses |
| 12/01/2004 | EP1481988A2 Procedure to obtain and use antibiotic peptides for the treatment of infectious diseases |
| 12/01/2004 | EP1481984A1 Modified hepatitis C virus (HCV) NS5 |
| 12/01/2004 | EP1481695A1 Formulations of hyaluronic acid for delivery of osteogenic proteins |
| 12/01/2004 | EP1481687A1 Use of multimeric ligands of the TNF family with reduced toxicity for treating cell proliferative diseases |
| 12/01/2004 | EP1481686A1 Use of multimeric ligands of the TNF family with reduced toxicity for treating cell proliferative diseases |
| 12/01/2004 | EP1481685A1 Use of PAM |
| 12/01/2004 | EP1481684A1 Remedies for liver diseases, hyperlipemia and diabetes |
| 12/01/2004 | EP1481683A1 P-selectin targeting ligand and compositions thereof |
| 12/01/2004 | EP1481668A1 Use of anti-glaucoma drugs to treat visual field defects associated with the use of a GABAergic agent |
| 12/01/2004 | EP1481667A1 NEP inhibitors for the treatment of female sexual dysfunction |
| 12/01/2004 | EP1481093A2 MODULATION OF TYPE II&bgr; PHOSPHOINOSITIDE PHOSPHATE KINASE |
| 12/01/2004 | EP1481090A1 Methods and reagents for detecting target binding by nucleic acid ligands |
| 12/01/2004 | EP1481081A2 Lipid-associated molecules |
| 12/01/2004 | EP1481078A2 Use of peptide-drug conjugation to reduce inter-subject variability of drug serum levels |
| 12/01/2004 | EP1481065A2 Method for detection of leptin receptor ligands |
| 12/01/2004 | EP1481061A2 Denaturat stable and/or protease resistant, chaperone-like oligomeric proteins, polynucleotides encoding same and their uses |
| 12/01/2004 | EP1481057A1 System and method for the production of recombinant glycosylated proteins in a prokaryotic host |
| 12/01/2004 | EP1481056A2 Modified human manganese superoxide dismutase and uses therof |
| 12/01/2004 | EP1481010A2 Anti-interleukin-1 beta analogs |
| 12/01/2004 | EP1481007A2 Spheron components useful in determining compounds capable of treating symptoms of alzheimer's disease, treatments and animal models produced therefrom |
| 12/01/2004 | EP1481005A1 Dab sp 9 /sp DERIVATIVES OF LIPOPEPTIDE ANTIBIOTICS AND METHODS OF MAKING AND USING THE SAME |
| 12/01/2004 | EP1481003A2 Hsp70-derived peptides an uses thereof in the diagnosis and treatment of autoimmune diseases |
| 12/01/2004 | EP1481002A1 Histogranin-like peptides and non-peptides, processes for their preparation and uses thereof |
| 12/01/2004 | EP1481001A2 Prion inhibiting peptides and derivatives thereof |
| 12/01/2004 | EP1481000A2 Novel peptides as ns3-serine protease inhibitors of hepatitis c virus |
| 12/01/2004 | EP1480999A2 (substituted)acyl dipeptidyl inhibitors of the ice/ced-3 family of cysteine proteases |
| 12/01/2004 | EP1480998A1 Intermediates and methods for making heptapeptide oxytocin analogues |
| 12/01/2004 | EP1480995A2 Cks1 INHIBITORS |
| 12/01/2004 | EP1480992A2 Telomerase interference |